AI health is experiencing explosive growth. After Ant Group's "Ant Afu" surpassed 30 million monthly active users and received over 10 million daily inquiries, OpenAI quickly responded by officially launching the ChatGPT Health feature, offering health Q&A, medical report interpretation, and smart device integration. However, compared to their capabilities, Ant Afu has built a "consultation - diagnosis - treatment" closed loop, while ChatGPT Health remains at the information assistance stage, highlighting the different paths of AI health development between China and the U.S.

image.png

 Ant Afu: The World's First Full-Chain AI Health Platform

As China's first AI health application, Ant Afu's new version has achieved three major breakthroughs:

- Service Loop:  

  - Daily health consultation → Online diagnosis (300,000 real doctors) → Offline appointment (connected to 5,000 hospitals nationwide);  

  - Supports insurance payment, electronic medical record retrieval, and examination scheduling throughout the process;

- Device Ecosystem:  

  Integrated with ten major brands including Apple, Huawei, OPPO, vivo, and Yuwell, supporting smartwatches, blood pressure monitors, and glucose meters, enabling automatic data synchronization;

- Health Companion:  

  Based on user vital signs and behavioral data, it provides personalized diet, exercise, and medication reminders, creating a "24-hour health manager".

Within one month of launch, monthly active users surged from 15 million to 30 million, proving the strong demand for proactive and integrated health services.

 ChatGPT Health: Focused on Data Integration, Lacking Medical Resources

Although ChatGPT Health has similar functions, it currently has significant shortcomings:

- ✅ Strengths:  

  - Deeply integrated with popular overseas health apps such as Apple Health and MyFitnessPal;  

  - Can interpret lab reports, generate lists of questions for medical visits, and create diet plans;  

  - Health conversations are independently encrypted, emphasizing privacy and security;

- ❌ Limitations:  

  - Does not connect to hospital appointments, online consultations, or doctor resources;  

  - Lacks local medical compliance certification (currently limited to U.S. electronic medical records);  

  - Does not support China's mainstream health devices (such as Huawei and Xiaomi bands).

Currently, ChatGPT Health is only available to a small group of early users, and full release will take several months.

 Different Paths Between China and the U.S.: Ecosystem Collaboration vs Model Capabilities

- Ant Afu: Relying on the Alipay ecosystem, Alibaba Health, hospital resources, and domestic device alliances, it follows a "service integration + local compliance" approach, achieving rapid large-scale deployment;

- ChatGPT Health: Relies on large model understanding and open APIs, following a "data aggregation + general AI" approach, which is strong in flexibility but weak in medical depth.

Although OpenAI acknowledges that "health is the most frequent scenario for ChatGPT (over 230 million weekly questions)," healthcare is a highly regulated, resource-intensive, and trust-based field. Relying solely on model capabilities is difficult to break through.

 AIbase Observation: AI Health Enters the "Service Implementation" Decisive Phase

When users no longer just want "AI tells me what disease I might have," but need "AI helps me book an expert appointment, schedule tests, and remind me to take medicine," medical resource integration has become the core barrier for AI health products.

The rapid rise of Ant Afu proves that in the Chinese market, AI health must "take root offline and connect services." OpenAI's follow-up indicates that global AI giants are fully betting on this field.